Stelios P. Pavlidis
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 10, 2024
Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts.
Journal: Respirology (Carlton, Vic.)
Published: December 11, 2021
Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.
Journal: Thorax
Published: December 03, 2021
Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort.
Journal: Clinical and translational medicine
Published: November 19, 2021
Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD.
Journal: Thorax
Published: July 06, 2021
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
Journal: The Journal of allergy and clinical immunology
Published: November 12, 2020
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase.
Journal: Nature communications
Published: August 12, 2020
Type 2-low asthma phenotypes by integration of sputum transcriptomics and serum proteomics.
Journal: Allergy
Published: May 19, 2020
Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
Journal: The European respiratory journal
Published: May 17, 2020
Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype.
Journal: Allergy
Published: February 24, 2020
Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.
Journal: Thoracic cancer
Published: August 29, 2019
Last Updated: 09/26/2026